# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-19-054384
Filing Date
2019-10-16
Accepted
2019-10-16 16:05:37
Documents
22
Period of Report
2019-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a19-20361_18k.htm | 8-K | 26721
2 | EX-99.1 | a19-20361_1ex99d1.htm | EX-99.1 | 33220
3 | GRAPHIC | g203611mmi001.gif | GRAPHIC | 187318
4 | GRAPHIC | g203611mmi002.gif | GRAPHIC | 145219
5 | GRAPHIC | g203611mmi003.gif | GRAPHIC | 115842
6 | GRAPHIC | g203611mmi004.gif | GRAPHIC | 83971
7 | GRAPHIC | g203611mmi005.gif | GRAPHIC | 116927
8 | GRAPHIC | g203611mmi006.gif | GRAPHIC | 83095
9 | GRAPHIC | g203611mmi007.gif | GRAPHIC | 119198
10 | GRAPHIC | g203611mmi008.gif | GRAPHIC | 72554
11 | GRAPHIC | g203611mmi009.gif | GRAPHIC | 103414
12 | GRAPHIC | g203611mmi010.gif | GRAPHIC | 101767
13 | GRAPHIC | g203611mmi011.gif | GRAPHIC | 98532
14 | GRAPHIC | g203611mmi012.gif | GRAPHIC | 172892
15 | GRAPHIC | g203611mmi013.gif | GRAPHIC | 83094
16 | GRAPHIC | g203611mmi014.gif | GRAPHIC | 125147
17 | GRAPHIC | g203611mmi015.gif | GRAPHIC | 90916
18 | GRAPHIC | g203611mmi016.gif | GRAPHIC | 96053
19 | GRAPHIC | g203611mmi017.gif | GRAPHIC | 129889
20 | GRAPHIC | g203611mmi018.gif | GRAPHIC | 92804
21 | GRAPHIC | g203611mmi019.gif | GRAPHIC | 129222
22 | GRAPHIC | g203611mmi020.gif | GRAPHIC | 100389
| Complete submission text file | 0001104659-19-054384.txt |  | 3160086

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 191152852
SIC: 2834 Pharmaceutical Preparations